DHF also enhanced the phosphorylation of TrkB and its downstream signaling pathway Akt, which was correlated with a downregulation in downstream NFkB signaling, indicating that enhancing TrkB activation is a potential therapeutic mechanism in HAND. The gene discussed is NFKB1; the disease is HIV-associated neurocognitive disorder.